MEDS Insider Trading Activity and SEC Form 4 Filings
MEDS insider trading summary
No open-market insider purchases or sales of TRxADE HEALTH, INC (MEDS) have been reported on SEC Form 4 in the past 12 months.
Latest MEDS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 25, 2022 | Donald G. Fell | Director | Buy | $2K (1,500 @ $1.08) |
| May 20, 2022 | Surendra K Ajjarapu | CEO | Buy | $130.0M (10,000 @ $13000.00) |
| May 12, 2022 | Donald G. Fell | Director | Buy | $3K (2,000 @ $1.26) |
| Jun 21, 2021 | Michael L Peterson | Insider | Sell | $4K (900 @ $4.45) |
| Apr 19, 2021 | Michael L Peterson | Director | Sell | $4K (900 @ $4.68) |
| Apr 19, 2021 | Prashant Patel | President | Sell | $33K (7,500 @ $4.39) |
| Dec 14, 2020 | Donald G. Fell | Director | Sell | $3K (500 @ $5.30) |
| Dec 14, 2020 | Michael L Peterson | Director | Sell | $9K (1,800 @ $5.26) |
| Dec 14, 2020 | Pamela Tenaerts | Director | Sell | $4K (800 @ $5.30) |
| Dec 14, 2020 | Prashant Patel | President | Sell | $40K (7,500 @ $5.29) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.